Magazine Article | May 2, 2018

Best Practices To Prevent Clinical Trial Protocol Deviations

Source: Life Science Leader

By Laurie Halloran

Protocols serve to protect the people who participate in clinical trials and provide standards so the data collected supports the study’s objectives. When protocols are not followed, it can create serious issues that slow down the study or significantly increase costs. These best practices can help sponsors and CROs work together seamlessly to prevent and alleviate protocol deviations in their clinical studies, keeping development on time and within budget.

The guideline for Good Clinical Practice of the International Council on Harmonization (ICH GCP) defines the protocol as “A document that describes the objective(s), design, methodology, statistical considerations, and organization of a trial.” Protocols should be written in a clear and concise manner to provide all study personnel with a comprehensive understanding of the disease, the study’s population, and the investigational agent. Consideration must also be given to the burden that will be placed on subjects to participate and investigators to administer with integrity and rigor.

VIEW THE MAGAZINE ARTICLE!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of Life Science Leader? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
I'm interested in newsletter subscriptions.
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: